GlassScriptPhysician profile
Arash Momeni
NPI 1457515645
$836,307.50
in general payments reported to CMS, 2019-2025
17 companies · $9,198 in 2025
The $9,198 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $103K · 2021: $173K · 2022: $94K · 2023: $384K · 2024: $14K · 2025: $9,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $263K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $128K · Travel and Lodging: $9,802 · Food and Beverage: $5,803 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $263,053.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $127,875.00 |
| Travel and Lodging | $9,802.06 |
| Food and Beverage | $5,803.21 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $685,205.64 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Axogen | $77,760.21 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Stryker Corporation | $31,056.73 | 2019-2022 | |
| Rti Surgical, INC | $21,520.45 | 2021-2025 | |
| Allergan, INC. | $6,666.67 | 2019-2022 | |
| Integra Lifesciences Corporation | $5,397.80 | 2020-2024 | Durasorb Monofilament Mesh, Surgimend, Codman Certas |
| W. L. Gore & Associates, INC. | $4,225.00 | 2023 | Product In Development |
| Davol INC. | $928.47 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Becton, Dickinson and Company | $815.12 | 2022-2025 | Phasix Mesh |
| Abbvie INC. | $781.75 | 2023-2025 | |
| Motiva USA, LLC | $525.18 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $518.19 | 2021 | |
| Tela Bio, INC. | $443.57 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sanara Medtech INC. | $157.79 | 2024 | Celleraterx |
| Ethicon US, LLC | $155.52 | 2025 | Vistaseal, Surgicel Nu-Knit, Harmonic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $78.88 | 2019 | |
| Mentor Worldwide LLC | $70.53 | 2022-2025 | Mentor Cpx 2 Breast Tissue Expander |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Momeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.